No abstract available
MeSH terms
-
Adult
-
Age Factors
-
Antilymphocyte Serum / therapeutic use
-
Graft Rejection / immunology
-
Graft Rejection / therapy
-
Graft Survival*
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Middle Aged
-
Muromonab-CD3 / therapeutic use
-
Pancreas Transplantation / methods
-
Pancreas Transplantation / pathology
-
Pancreas Transplantation / physiology*
-
Retrospective Studies
-
Survival Analysis
-
Time Factors
-
Tissue Donors
-
Treatment Outcome
Substances
-
Antilymphocyte Serum
-
Immunosuppressive Agents
-
Muromonab-CD3